Our study reported the prognostic significance of RIPK3 expression in the general population of lung cancer patients regardless of adjuvant therapy in contrast to a previous study that reported the prognostic value of RIPK3 in a specific subgroup of patients who had received adjuvant chemotherapy [32]. This evidence concerns the gene RIPK3 and lung carcinoma.